Clinical trial Recruiting at 5 sites Observational Ages 18 and up

Analyzing cancer genetics for better prevention and treatment

Official title: INTERogating Cancer for Etiology, Prevention and Therapy Navigation (INTERCEPTioN)

Run by Mayo Clinic · NCT06008392 · Data updated 2026-11-12

This study is trying to find genetic clues in cancer patients' samples to improve prevention and treatment options for cancer.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorMayo Clinic
Academic / other
Locations5 sites (Scottsdale, Arizona and 4 other locations)
StatusRecruiting
StartedOctober 12, 2023
Main results expectedSeptember 2033
Study endsSeptember 2033
Registry record updatedOctober 16, 2026
Trial IDNCT06008392 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a confirmed cancer diagnosis who can provide genetic samples and are aware of their condition.

Probably not a fit

Patients who are not diagnosed with cancer or unable to provide the necessary samples may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify genetic markers and causes of cancer by analyzing patients' DNA, RNA, plasma, tissues, and other samples. It focuses on cancer genetic testing to find specific changes in cancer and normal cells, which may lead to improved prevention, screening, and treatment strategies. Additionally, the study will create a biobank of samples and information to further research in cancer treatment. Participants will undergo pan-genomic testing to discover genetic variants that could enhance cancer management.

Why it matters

Potential benefit: If successful, this study could lead to earlier diagnosis and more effective therapies for cancer patients.

How similar studies have gone: Other studies utilizing genetic testing for cancer have shown promising results, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

GROUP A: Germline and Somatic Testing

* Has Mayo Clinic medical record number
* Confirmed cancer diagnosis
* Germline and/or somatic tumor/blood testing has been ordered by the clinical provider (or clinical delegate)
* Participant aware of cancer diagnosis
* Able to provide informed consent
* ≥ 18 years old
* Ability to provide blood, saliva, bone marrow aspirate or hair follicle sample
* Ability to provide archived tissue, if somatic testing has not already been completed

  * Note: if tissue unavailable participant may still enroll onto the study for the germline collection, or vice versa, if germline has already been completed may still enroll for somatic tissue/blood testing.

GROUP B: Germline testing only:

* Has Mayo Clinic medical record number
* Confirmed cancer diagnosis
* Germline testing has been ordered by the clinical provider (or clinical delegate)
* Participant aware of cancer diagnosis
* Able to provide informed consent
* ≥ 18 years old
* Ability to provide blood, saliva, or hair follicle sample

GROUP C: Somatic tumor testing only:

* Has Mayo Clinic medical record number,
* Confirmed cancer diagnosis,
* Somatic tumor/blood testing has been ordered by the clinical provider (or clinical delegate)
* Participant aware of cancer diagnosis,
* Able to provide informed consent,
* ≥ 18 years old
* Ability to provide archived tissue or blood for somatic tumor genomic profiling, if not already completed.

Group D: Clinical standard of care germline testing via genetic counselor:

* Has Mayo Clinic medical record number,
* Standard of care clinical visit with genetic counselor
* Confirmed cancer diagnosis,
* Germline testing has been ordered by the clinical provider (or clinical delegate)
* Participant aware of cancer diagnosis,
* Able to provide informed consent,
* ≥ 18 years old
* Ability to provide blood, saliva, or hair follicle sample

Group E: Previous Enrollment in IRB #24-005734, 24-000609, 25-000815, 23-001689, or 24-004810:

* Enrolled in any of the following studies: IRB #24-005734, 24-000609, 25-000815, 23-001689, or 24-004810
* Completed Riskguard, OncoExtra, Caris Assure, or Caris MI Profile or any combination of these tests.
* Has Mayo Clinic medical record number,
* Confirmed cancer diagnosis,
* Participant aware of cancer diagnosis
* Able to provide informed consent,
* ≥ 18 years old

Exclusion Criteria:

Note: Women who are pregnant or planning to become pregnant can take part in this study.

GROUP A: Germline and Somatic testing

* Individuals who have situations that would limit compliance with the study requirements
* Institutionalized (i.e. Federal Medical Prison)

GROUP B: Germline testing only

* Individuals who have situations that would limit compliance with the study requirements
* Institutionalized (i.e. Federal Medical Prison)
* Prior germline genetic testing with a 100+ multi-gene panel within the last 1 year of enrollment

Group C: Somatic tumor testing only:

* Individuals who have situations that would limit compliance with the study requirements,
* Institutionalized (i.e. Federal Medical Prison),

Group D: Clinical standard of care germline testing via genetic counselor:

* Individuals who have situations that would limit compliance with the study requirements,
* Institutionalized (i.e. Federal Medical Prison)

Group E: Previous Enrollment in IRB #24-005734, 24-000609, 25-000815, 23-001689, or 24-004810:

* Individuals who have situations that would limit compliance with the study requirements,
* Institutionalized (i.e. Federal Medical Prison)

Where it's running

  • Mayo Clinic in Arizona
    Scottsdale, Arizona, United States
    Recruiting
  • Mayo Clinic in Florida
    Jacksonville, Florida, United States
    Recruiting
  • Mayo Clinic in Rochester
    Rochester, Minnesota, United States
    Recruiting
  • Mayo Clinic Health System-Eau Claire Clinic
    Eau Claire, Wisconsin, United States
    Recruiting
  • Mayo Clinic Health System-Franciscan Healthcare
    La Crosse, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.